Correlated Drug Terms (0)

---

	Name (Synonyms)	Correlation

Correlated MeSH Terms (1)

---

	Name (Synonyms)	Correlation
D007239	Infection NIH	0.06

Correlated HPO Terms (0)

---

	Name (Synonyms)	Correlation

Primary Outcomes

Description: Defined as SPO2≤ 93% without oxygen supplementation, PaO2/FiO2 ≤ 300mmHg or a respiratory rate ≥30 breaths per min without supplemental oxygen min without supplemental oxygen

Measure: Rate of composite adverse outcomes

Time: Within 10 days after administration

---

Secondary Outcomes

Description: Clinical recovery was defined as sustained (48 hours) alleviation of illness based on symptom scores (fever, cough, diarrhea, myalgia, dyspnea) all being absent and no evidence for progression (newly-presented dyspnea, SpO2 decline ≥3%, respiratory rate ≥ 30 breaths per min without supplemental oxygen).

Measure: Time to recovery

Time: Within 10 days after administration

---

Measure: Rate of no fever

Time: Within 10 days after administration

---

Measure: Rate of no cough

Time: Within 10 days after administration

---

Measure: Rate of no dyspnea

Time: Within 10 days after administration

---

Measure: Rate of no requiring supplemental oxygen

Time: Within 10 days after administration

---

Measure: Rate of undetectable New coronavirus pathogen nucleic acid

Time: Within 10 days after administration

---

Measure: Rate of mechanical ventilation

Time: Within 10 days after administration

---

Measure: Rate of ICU admission

Time: Within 10 days after administration

---

Measure: Rate of serious adverse event

Time: Within 10 days after administration

---